Trending Now Cd4 Monoclonal Antibody (rpa-t4), Novafluor™ Blue 585 Bonkers Deal: 35% Off [bL9ASMwa]

CD4 Monoclonal Antibody: Advanced HIV Research Tool

The Trending Now Cd4 Monoclonal Antibody (rpa-t4), Novafluor™ Blue 585 Bonkers Deal: 35% Off [bL9ASMwa], is a cutting-edge reagent designed for researchers in the field of HIV/AIDS. This antibody specifically targets human CD4, a crucial receptor expressed on a variety of immune cells. With its NovaFluor™ Blue 585 conjugation, it offers exceptional fluorescence and is ideal for flow cytometric analysis. The RPA-T4 antibody stands out for its ability to block HIV binding and mixed lymphocyte reactions, making it a valuable tool for understanding the complex interactions between CD4 and HIV.

Key Product Properties and Specifications

The RPA-T4 monoclonal antibody recognizes a unique epitope on the CD4 receptor, distinguishing it from the OKT4 antibody. This specificity ensures that the RPA-T4 does not cross-block binding with the OKT4, providing researchers with a reliable tool for their studies. Each NovaFluor conjugate is shipped with CellBlox Blocking Buffer, which is essential for optimal staining with NovaFluor conjugates. The antibody is pre-diluted for convenient use in flow cytometric analysis, with a recommended dosage of 5 µL per test. This product is compatible with a wide range of cell samples, allowing for flexibility in experimental design.

Practical Applications and Target Audience

The Trending Now Cd4 Monoclonal Antibody (rpa-t4), Novafluor™ Blue 585 Bonkers Deal: 35% Off [bL9ASMwa], is a vital resource for researchers in virology, immunology, and infectious diseases. Its applications extend to various aspects of HIV research, including the study of HIV entry into host cells and the analysis of T-cell subsets. This antibody is particularly beneficial for those working on understanding the immune response to HIV and developing novel therapeutic strategies. By offering a reliable and efficient tool for flow cytometric analysis, this product empowers researchers to advance their studies and contribute to the fight against HIV/AIDS.